Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Controlled co-delivery of anti-inflammatory drugs from bilayer polymer films coating a meniscus implant

  • Fernández Blanco, Alfonso
  • Lou, Gustavo
  • Pensado-López, Alba
  • Ummarino, Aldo
  • Torres Andón, Fernando
  • Crecente Campo, José
  • Alonso Fernández, María José
Knee osteoarthritis (OA), a degenerative joint disease, is increasingly prevalent worldwide and often results from a meniscal deterioration that leads to meniscus removal. Replacing the damaged meniscus with a non-biodegradable prosthesis offers an innovative solution to prevent OA progression, particularly in older patients. However, the long-term use of anti-inflammatory drugs for pain relief and prosthesis integration can cause severe off-target side effects. The objective of this work was to design and develop drug-loaded bilayer polymer films to be used as coatings for a meniscus polycarbonate urethane (PCU). The developed bilayer polymer films enabled a sustained release of two anti-inflammatory drugs - dexamethasone (DEX) and celecoxib (CLX) - with distinct release kinetics (1–4 weeks for DEX and 6–9 months for CLX). This release profile was defined to modulate post-surgical and chronic inflammation within the knee joint, respectively. Two bilayer prototypes showed consistent biodegradation, drug release, drug loading, and reproducibility. Furthermore, the systems were sterile, biocompatible, and maintained the anti-inflammatory efficacy of the released drugs, effectively reducing pro-inflammatory cytokine secretion from human primary macrophages.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery

  • Abbadessa, Anna
  • Crecente Campo, José
  • Alonso Fernández, María José
Human meniscus is a fibrocartilaginous structure that is crucial for an adequate performance of the human knee joint. Degeneration of the meniscus is often followed by partial or total meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a satisfactory treatment for this condition has triggered a major interest in drug delivery (DD) and tissue engineering (TE) strategies intended to restore a bioactive and fully functional meniscal tissue. The aim of this review is to critically discuss the most relevant studies on spatiotemporal DD and TE, aiming for a multizonal meniscal reconstruction. Indeed, the development of meniscal tissue implants should involve a provision for adequate active molecules and scaffold features that take into account the anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the meniscus biochemical composition, collagen fiber arrangement, and cell distribution. In this sense, it is expected that a proper combination of advanced DD and zonal TE strategies will play a key role in the future trends in meniscus regeneration
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery

  • Abbadessa, Anna
  • Crecente Campo, José
  • Alonso Fernández, María José
Human meniscus is a fibrocartilaginous structure that is crucial for an adequate performance of the human knee joint. Degeneration of the meniscus is often followed by partial or total meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a satisfactory treatment for this condition has triggered a major interest in drug delivery (DD) and tissue engineering (TE) strategies intended to restore a bioactive and fully functional meniscal tissue. The aim of this review is to critically discuss the most relevant studies on spatiotemporal DD and TE, aiming for a multizonal meniscal reconstruction. Indeed, the development of meniscal tissue implants should involve a provision for adequate active molecules and scaffold features that take into account the anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the meniscus biochemical composition, collagen fiber arrangement, and cell distribution. In this sense, it is expected that a proper combination of advanced DD and zonal TE strategies will play a key role in the future trends in meniscus regeneration
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Polymer Coating Adhesion Drives Functional and Biological Outcomes in Meniscus Implants

  • Blanco, Alfonso F.
  • Rubio Prego, Inés
  • Bao-Varela, Carmen
  • Bouza, Rebeca
  • Núñez Bernal, Paulina
  • Levato, Riccardo
  • Malda, Jos
  • Kon, Elizaveta
  • Crecente-Campo, José
  • Alonso, M. J.
[Abstract]: Achieving stable integration of drug-releasing polymer coatings with load-bearing meniscus implants remains a challenge in biomaterials engineering. In this study, four surface modification strategies, femtosecond-pulsed laser treatment, oxygen plasma, polydopamine, and an ethyl-2-cyanoacrylate (ECA) interlayer, were evaluated for the integration of a dexamethasone (DEX)- and celecoxib (CLX)-releasing bilayer coating with a polycarbonate urethane (PCU) meniscus implant. The selected construct comprised an ECA interlayer applied from a 40% (w/v) solution, a CLX-loaded PLLA/PCL layer prepared at 100 mg/mL and a 53/47 (w/w) polymer ratio with 16.6% CLX loading, and an outer DEX-loaded PLGA layer prepared at 200 mg/mL with 2.44% DEX loading. At 37 °C, compared with uncoated PCU, ECA-containing constructs showed significantly higher storage modulus, loss modulus, and elastic modulus (p < 0.05), while tan δ remained unchanged, indicating preservation of the elastic-dominant viscoelastic response of the complete construct. The ECA-containing coating was subsequently adapted to the geometry of a sheep meniscus implant using an optimized dip-coating procedure. During a 21-day bioreactor study, repeated compression and shear increased cumulative DEX release from 59 to 67% and CLX release from 25 to 40% relative to static controls, while no visible coating delamination was observed. Ethylene oxide sterilization preserved drug loading and release behavior. In an exploratory threemonth sheep study, the fiber-fixed coated implants remained in position, and the coating remained macroscopically associated with the retrieved prostheses. These findings support the use of an ECA interlayer to integrate a bilayer drug-releasing coating with a PCU meniscus implant while preserving construct-level mechanical behavior and drug release under the conditions evaluated., This project has received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 814444 (MEFISTO). Alfonso F. Blanco has received research support through a predoctoral grant from Xunta de Galicia, Grant No. ED481A 2022/066. Inés RubioPrego acknowledges a grant (IFI23/00035) from Instituto de Salud Carlos III “Contratos i-PFIS: Doctorados IIS-empresa en Ciencias y Tecnologías de la Salud”. Carmen Bao-Varela acknowledges financial support under grant PID2022- 138322OB-100 funded by MCIN/ AEI/ 10.13039/ 501100011033 and by “ERDF A way of making Europe” and the support of Xunta under grant ED431B 2023/07. The graphical artwork was created by the authors. BioRender (www.biorender.com) was used as a graphical design tool for the figures indicated in the corresponding captions., Xunta de Galicia; ED481A 2022/066, Xunta de Galicia; ED431B 2023/07